In a mouse model of NAFLD induced by a high-fat (HF) diet, icariin alleviated hepatic injury by improving glucose tolerance and lipid metabolism via the activation of the AMPK/PGC-1α/GLUT4 pathway [18]. Here, PPARGC1A is linked to metabolic dysfunction-associated steatotic liver disease.